Previous Close | 18.11 |
Open | 18.09 |
Bid | 0.00 x N/A |
Ask | 0.00 x N/A |
Day's Range | 18.09 - 18.75 |
52 Week Range | 10.04 - 21.80 |
Volume | |
Avg. Volume | 145 |
Market Cap | 4.7B |
Beta (5Y Monthly) | 0.79 |
PE Ratio (TTM) | 4.76 |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | 1.05 (5.80%) |
Ex-Dividend Date | May 10, 2024 |
1y Target Est | N/A |
JERSEY CITY, N.J., May 02, 2024--Organon Reports Results for the First Quarter Ended March 31, 2024
JERSEY CITY, N.J., April 08, 2024--Organon To Report First Quarter 2024 Results and Host Conference Call on May 2, 2024
SHANGHAI, China & JERSEY CITY, N.J., April 08, 2024--Organon and Henlius announce that Phase 3 Comparative Clinical Study of Prolia® and Xgeva® (denosumab) Biosimilar Candidate HLX14 Met Primary Endpoint